Their clinical manifestations include hypogammaglobulinemia, decreased B and T cell counts, and lymphopenia, suggesting that rapidly dividing adaptive immune cells are more sensitive to LIG1 perturbations [12]. This evidence concerns the gene LIG1 and lymphopenia.